Poster discussion hub abstracts forms to capture new parameters and training providers in U/S techniques. This was followed by a one-year implementation/observation phase. The acceptability and feasibility of implementation was assessed by using qualitative and quantitative clinical indicators. Results: We will report on nurse/sonographer perceptions of the feasibility and acceptability of introducing new U/S techniques and tools for gestational dating. We will also report quantitative indicators of fidelity to the new protocol based on uptake of gestational dating U/S and completeness of documentation. Conclusions: As we navigate the successes and challenges related to implementing the INTERGROWTH-21st U/S tools into JH, we hope to contribute to a wider discussion regarding improvements in accurate gestational dating and fetal and newborn growth, specifically in other low resource settings. Objectives: To analyse pregnancy risk factors, complications and association with pregnancy outcomes in early-and late-onset fetal growth restriction. Methods: A retrospective study was conducted, including 77 early FGR and 100 late FGR, which EFW by ultrasound were below the 10 th percentile for gestational age and birth weight were less than 2.5 kilograms. All pregnancy women filled in a questionnaire including general health, past medical and obstetric history, high risk factors of the pregnancy. Ultrasound evaluation indicators included fetal growth and development, EFW, Doppler indices of UA, MCA, DV and fetal cardiac function (myocardial performance index, MPI and stroke volume, SV). The pregnancy outcomes of all cases were followed up to fill in the results table, included gestational age and mode of delivery, fetal weight, sex, Apgars scores and NICU admission. Results: Pregnancy complications were the first with 38.98%, included hypertension, thyroid disease, gestational diabetes, anemia, infection. Placenta factor and umbilical cord factor was the second with 15.82%. Fetal factors associated with structural abnormalities were the third with 9.6%. Sixty-six cases without pregnancy complications with 12.99%. Gestational hypertension, placenta umbilical cord factors, fetal abnormalities were common pregnancy complications. Objectives: To establish a normogram of the thymus area (TA), thymus transverse diameter (TTD) and thymus anterior-posterior thickness (APT) of the fetal thymus in second trimester (18 to 28 week) of pregnancy by 2D ultrasound. Methods: The present study is prospective and cross sectional. Fetal thymus was measured in 330 normal fetuses between 18 to 28 weeks of gestation using GE Volusion E10-BT/E8-BT 13.5 ultrasound device with a transabdominal C5-9, 9L, RAB6-D transducers at Paras advanced centre for fetal medicine between January 2017 and September 2017.
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Fetal thymus measurement normogram were developed by measuring thymic area by trace method, thymus transverse diameter and anteroposterior thickness of thymus and linear regression curve was developed. Results: The TA, TTD and APT of the thymus were measured simultaneously in 330 normal fetuses and all parameters increased with increasing gestational age in a linear manner. The regression equation for TA = 0.0114x 2 -0.3277x + 3.0241, for TTD = 0.0544x 2 -1.2903x + 17.326, for APT = 0.018x 2 + 0.0857x -1.1389. Conclusions: This study presents normogram of ultrasound measurements of fetal thymus in Indian population. We developed the fetal thymic normogram for thymic area (TA), transverse thymic diameter (TTD) and anteroposterior thickness of thymus (APT) so one can utilise any parameter for fetal thymus measurement in case of thymic evaluation for thymic hypoplasia especially when associated with cardiac malformation when accurate thymic measurement may not be possible by one fix thymic measurement. Objectives: DV is usually used for timing the delivery in IUGR fetuses. The aim of this study was to investigate the relationship between abnormal blood flow in DV and intrauterine fetal demise (IUFD), cord blood pH, base excess (BE) at birth considering time lasted between ultrasound and birth. Methods: 150 consecutive early IUGR fetuses that underwent ultrasound assessment of DV were considered. The DV was related to IUFD and fetal acid base status at birth. An abnormal DV was considered that with absent or reverse A-wave. Time between first ultrasound examination and birth was considered. Results: The mean gestational age at delivery was 29.4 weeks (±1.75) and the mean gestational age at first ultrasound was 28.8 weeks (±2.00) in the group with normal DV and 28.43 (±2.09) in the group with abnormal DV. Mean fetal weight at birth was 875.69 grams (±224.62). Abnormal DV was present in 44 cases (29.33%). There were 6 (4%) IUFD, abnormal cord blood pH was present in 70 (48.61%), and BE in 63 (43.75%). Perinatal mortality rate was 21.33% (32/150). Fetuses with abnormal DV had a significant increased risk of IUFD with a cumulative risk of 12% (CI.95 0-22%) during the first day versus 0% in normal DV (p<0.05). In normal DV fetuses the cumulative risk of IUFD at 10 days was 5% (CI.95 0-11%) and was lower respect to abnormal DV (p<0.05). In the abnormal DV there was an increased risk of abnormal cord blood pH or BE (p<0.05). In the abnormal DV neonatal death was not associated with abnormal cord blood pH or BE at birth. The only significant correlation was between abnormal cord blood pH at birth and neonatal mortality in the normal DV waveform group (p<0.05). No significant differences were found in morbidity between the two groups. Conclusions: This study shows how a normal or abnormal DV does not reduce IUFD, but is related to a worse acid-base status of the fetuses. This result should be considered as the mortality rate may increase in DV abnormalities while this in not significant for morbidity.
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Maternal uterine artery Doppler changes in pre-eclampsia and fetal growth restriction Objectives: Uterine artery Doppler (UtAD) is an imperfect screening test for pre-eclampsia (PE) and fetal growth restriction (FGR), with better screening performance for early onset complications. We have shown that maternal cardiac output is lower than healthy pregnancies in women with PE+FGR and FGR and higher than healthy pregnancies in PE. We sought to determine whether UtAD characteristics were different in these groups that are based on maternal hemodynamic function rather than by gestation at onset of disease. Methods: Women between 24-40 weeks gestation were prospectively recruited into 3 groups -pre-eclampsia (PE, n=13), fetal growth restriction with or without pre-eclampsia (FGR/PE+FGR, n=32) and healthy controls (n=62). PE was defined as maternal blood pressure of > 140/90 mmHg and urine protein creatinine ratio of > 30. FGR was defined as fetal abdominal circumference < 10th percentile and umbilical Doppler PI > 95th centile. Those with chronic hypertension or fetal anomaly were excluded. UtAD was performed and mean PI recorded. Results: Mean UtAD PI was significantly raised in FGR/PE+FGR (mean= 1.5, SD= 0.55; P=0.0001) compared to controls (mean=0.8, SD=0.24) but not different in pregnancies with PE only (mean=0.92, SD=0.33; p=1.00). Conclusions: UtAD impedance was higher in FGR/PE+FGR than controls, and no different between PE and controls. This may explain the apparent paradox in the screening performance of UtAD impedance, which appears to be closely related to the conditions associated with low maternal cardiac output-these conditions being most commonly encountered though not exclusively so at early gestation.
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